No Data
Barclays Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $51
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and UnitedHealth (UNH)
Express News | Ionis Pharmaceuticals Inc : Oppenheimer Raises Target Price to $78 From $75
A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $59 to $67
Sector Update: Health Care Stocks Mixed Premarket Friday
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts